Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Recruiting
Observational Study
Breast Cancer Detection
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Breast Cancer Female
Breast Cancer - Ductal Carcinoma in Situ (DCIS)
Breast Cancer - Infiltrating Ductal Carcinoma
Breast Cancer With Low to Intermediate HER2 Expression
Breast Cancer (Early Breast Cancer)
Breast Cancer - Female
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 – 70
- Sex
- Female
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Oncoliq US Inc · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cancer continues to be one of the most significant public health issues worldwide. Thanks to early detection, the mortality rate of certain types of cancer has decreased significantly. However, the lack of accessible, low-cost, non-invasive, non-toxic, and easy-to-implement diagnostic methods results in late diagnoses, leading to 1 in every 6 people dying from cancer today.
MicroRNAs (miRNAs) are…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Group 1 - Breast Cancer:
Age between 40 and 70 years Diagnosis of breast cancer at any stage No prior surgical treatment No prior antineoplastic treatment Pathology report available at the time of enrollment Signed informed consent
Group 2 - No Cancer (Control):
Age between 5…
Contacts